NASDAQ : ENVB
Enveric Biosciences, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 1.43 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 6.40M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Selling, General & Admin | 6.10M | 5.79M | 6.45M | 8.85M | 11.73M | 19.88M |
| Research & Development | 2.48M | 2.78M | 2.84M | 7.25M | 7.91M | 4.76M |
| Operating Expenses | 8.73M | 8.77M | 9.63M | 16.45M | 19.96M | 25.29M |
| Operating Income | -8.73M | -8.77M | -9.63M | -16.45M | -19.96M | -25.29M |
| Interest Expense | -571.00 | -106.00 | -5.25K | -10.32K | ||
| Interest & Investment Income | 219.00 | 3.71K | ||||
| Other Non Operating Income (Expenses) | 2.00 | 2.57K | 65.99K | -818.09K | 7.46M | 8.20M |
| EBT Excluding Unusual Items | -8.73M | -8.77M | -9.57M | -17.26M | -12.50M | -17.10M |
| Merger & Restructuring Charges | -650.00K | |||||
| Impairment of Goodwill | -1.49M | -8.23M | ||||
| Asset Writedown | -5.97M | -30.45M | ||||
| Pretax Income | -8.73M | -8.77M | -9.57M | -17.26M | -19.96M | -56.43M |
| Income Tax Expense | 8.93K | 28.91K | -1.49M | -7.45M | ||
| Net Income | -8.73M | -8.77M | -9.57M | -17.29M | -18.47M | -48.98M |
| Preferred Dividends & Other Adjustments | 3.36M | 3.36M | 167.03K | 328.99K | ||
| Net Income to Common | -12.09M | -12.13M | -9.57M | -17.46M | -18.80M | -48.98M |
| Shares Outstanding (Basic) | 1.62M | 334.72K | 41.91K | 11.99K | ||
| Shares Outstanding (Diluted) | 1.62M | 334.72K | 41.91K | 11.99K | ||
| EPS (Basic) | -7.48 | -36.24 | -228.48 | -1,455.50 | ||
| EPS (Diluted) | -7.48 | -36.24 | -228.48 | -1,455.50 | ||
| Free Cash Flow | -8.56M | -8.14M | -7.73M | -14.10M | -17.73M | -11.65M |
| Free Cash Flow Per Share | -5.30 | -24.32 | -184.36 | -1,175.46 | ||
| EBITDA | -8.57M | -8.57M | -9.29M | -16.10M | -19.63M | -24.64M |
| D&A For EBITDA | 153.92K | 200.86K | 337.49K | 343.98K | 327.91K | 656.64K |
| EBIT | -8.73M | -8.77M | -9.63M | -16.45M | -19.96M | -25.29M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 8.30M | 4.68M | 2.24M | 2.29M | 17.72M | 17.36M |
| Cash & Short-Term Investments | 8.30M | 4.68M | 2.24M | 2.29M | 17.72M | 17.36M |
| Other Receivables | 224.61K | |||||
| Receivables | 224.61K | |||||
| Inventory | 74.43K | 45.24K | ||||
| Prepaid Expenses | 416.33K | 165.79K | 260.50K | 257.92K | 548.27K | 380.84K |
| Other Current Assets | 6.27K | 48.19K | 233.05K | 811.03K | 159.78K | |
| Total Current Assets | 8.79M | 4.94M | 2.73M | 3.58M | 18.43M | 17.74M |
| Property, Plant & Equipment | 81.93K | 159.23K | 305.78K | 507.38K | 741.30K | 470.73K |
| Goodwill | 1.59M | |||||
| Other Intangible Assets | 42.18K | 210.93K | 379.69K | 6.92M | ||
| Total Assets | 8.94M | 5.10M | 3.08M | 4.30M | 19.55M | 26.72M |
| Accounts Payable | 682.79K | 581.02K | 521.75K | 1.22M | 463.27K | 683.39K |
| Accrued Expenses | 178.68K | 337.38K | 967.99K | 756.00K | 1.71M | 1.29M |
| Current Portion of Leases | 63.82K | 107.44K | ||||
| Other Current Liabilities | 368.72K | 1.76M | ||||
| Total Current Liabilities | 861.48K | 918.40K | 1.49M | 2.34M | 4.00M | 2.08M |
| Long-Term Leases | 68.86K | |||||
| Long-Term Deferred Tax Liabilities | 1.61M | |||||
| Other Long-Term Liabilities | 653.67K | |||||
| Total Liabilities | 861.48K | 918.40K | 1.49M | 2.34M | 4.00M | 4.41M |
| Common Stock | 39.36K | 10.62K | 565.00 | 1.83K | 20.78K | 6.52K |
| Additional Paid-In Capital | 128.15M | 119.59M | 108.26M | 100.84M | 94.40M | 83.07M |
| Retained Earnings | -119.51M | -114.85M | -106.07M | -96.50M | -79.21M | -60.74M |
| Comprehensive Income & Other | -594.68K | -580.04K | -594.52K | -2.39M | -536.73K | -30.80K |
| Total Common Equity | 8.08M | 4.18M | 1.59M | 1.96M | 14.67M | 22.31M |
| Minority Interest | 885.03K | |||||
| Shareholders' Equity | 8.08M | 4.18M | 1.59M | 1.96M | 15.56M | 22.31M |
| Total Liabilities & Equity | 8.94M | 5.10M | 3.08M | 4.30M | 19.55M | 26.72M |
| Total Debt | 63.82K | 176.30K | ||||
| Net Cash (Debt) | 8.30M | 4.68M | 2.24M | 2.29M | 17.66M | 17.18M |
| Net Cash Per Share | 5.14 | 13.97 | 53.47 | 190.74 | ||
| Filing Date Shares Outstanding | 4.48M | 1.89M | 205.97K | 40.52K | 11.55K | 5.84K |
| Total Common Shares Outstanding | 3.94M | 1.06M | 56.50K | 15.22K | 11.55K | 3.62K |
| Working Capital | 7.93M | 4.02M | 1.24M | 1.24M | 14.44M | 15.65M |
| Book Value Per Share | 2.05 | 3.94 | 28.19 | 128.55 | 1,270.74 | 6,161.86 |
| Tangible Book Value | 8.08M | 4.18M | 1.55M | 1.75M | 14.29M | 13.79M |
| Tangible Book Value Per Share | 2.05 | 3.94 | 27.44 | 114.69 | 1,237.85 | 3,810.60 |
| Machinery | 805.18K | 834.79K | 795.18K | 865.09K | 856.26K | 321.77K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -8.73M | -8.77M | -9.57M | -17.29M | -18.47M | -48.98M |
| Depreciation & Amortization | 153.92K | 200.86K | 337.49K | 408.03K | 435.20K | 681.61K |
| Loss (Gain) From Sale of Assets | -4.21K | |||||
| Asset Writedown & Restructuring Costs | 7.45M | 38.68M | ||||
| Stock-Based Compensation | 641.00K | 827.32K | 1.56M | 2.15M | 2.62M | 12.63M |
| Other Operating Activities | -79.63K | -101.80K | 372.21K | 818.09K | -8.97M | -15.66M |
| Change in Accounts Payable | -400.93K | -413.86K | -834.63K | -103.85K | 263.69K | 383.20K |
| Change in Other Net Operating Assets | -146.51K | 117.92K | 411.39K | -70.90K | -481.35K | 801.87K |
| Operating Cash Flow | -8.56M | -8.14M | -7.73M | -14.09M | -17.15M | -11.46M |
| Capital Expenditures | -5.18K | -584.16K | -189.72K | |||
| Sale of Property, Plant & Equipment | 16.85K | |||||
| Cash Acquisitions | 3.06M | |||||
| Sale (Purchase) of Intangibles | -675.00K | |||||
| Investing Cash Flow | 11.67K | -584.16K | 2.19M | |||
| Issuance of Common Stock | 14.05M | 10.58M | 6.05M | 17.22M | 24.90M | |
| Other Financing Activities | -18.84K | 1.62M | -1.34M | 958.04K | ||
| Financing Cash Flow | 14.03M | 10.58M | 7.67M | -1.34M | 18.18M | 24.90M |
| Foreign Exchange Rate Adjustments | -22.03K | -1.50K | 5.35K | -10.02K | -81.36K | 144.94K |
| Net Cash Flow | 5.45M | 2.44M | -46.95K | -15.44M | 367.88K | 15.78M |
| Free Cash Flow | -8.56M | -8.14M | -7.73M | -14.10M | -17.73M | -11.65M |
| Free Cash Flow Per Share | -5.30 | -24.32 | -184.36 | -1,175.46 | ||
| Levered Free Cash Flow | -5.20M | -4.79M | -4.16M | -9.90M | -8.38M | -1.75M |
| Unlevered Free Cash Flow | -5.20M | -4.79M | -4.16M | -9.90M | -8.38M | -1.75M |
| Cash Interest Paid | 5.25K | 10.32K | ||||
| Cash Income Tax Paid | 5.00K | 9.51K | ||||
| Change in Working Capital | -547.44K | -295.94K | -423.24K | -174.75K | -217.66K | 1.19M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 6.40M | 3.71M | 3.64M | 3.02M | 4.32M | 29.19M |
| Enterprise Value | -1.90M | -42.77K | 533.18K | -1.25M | -16.03M | 7.74M |
| Last Close Price | 1.43 | 3.63 | 64.51 | 234.00 | 374.40 | 8,370.00 |
| PB Ratio | 0.70 | 0.89 | 2.29 | 1.54 | 0.28 | 1.31 |
| P/TBV Ratio | 0.79 | 0.89 | 2.35 | 1.73 | 0.30 | 2.12 |
| Debt / Equity Ratio | 0.00 | 0.01 | ||||
| Net Debt / Equity Ratio | -1.03 | -1.12 | -1.41 | -1.17 | -1.14 | -0.77 |
| Net Debt / EBITDA Ratio | 0.97 | 0.55 | 0.24 | 0.14 | 0.90 | 0.70 |
| Net Debt / FCF Ratio | 0.97 | 0.57 | 0.29 | 0.16 | 1.00 | 1.48 |
| Quick Ratio | 9.63 | 5.09 | 1.50 | 1.07 | 4.43 | 8.33 |
| Current Ratio | 10.21 | 5.38 | 1.84 | 1.53 | 4.61 | 8.51 |
| Return on Equity (ROE) | -170.04% | -304.04% | -539.57% | -197.47% | -97.57% | -380.82% |
| Return on Assets (ROA) | -87.34% | -134.11% | -163.09% | -86.20% | -53.92% | -102.60% |
| Return on Capital Employed (ROCE) | -108.00% | -210.00% | -604.70% | -840.80% | -128.30% | -102.70% |
| Earnings Yield | -523.30% | -236.13% | -262.70% | -573.02% | -427.33% | -167.81% |
| FCF Yield | -133.76% | -219.16% | -211.97% | -467.23% | -410.21% | -39.91% |
| Buyback Yield / Dilution | -1,279.44% | -698.70% | -249.38% |